APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Release Testing

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pharmaceutical Release Testing Industry Research Report 2026

12 August 2026141 pages

Choose your research edition.

Industry ResearchPharmaceutical Release Testing Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Release Testing Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Release Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Release Testing Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Release Testing Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Pharmaceutical Release Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Pharmaceutical Release Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Release Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Release Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Release Testing include Charles River Laboratories, SGS SA, Catalent, Inc., WuXi AppTec, Intertek Group plc, Labcorp Holdings, Samsung Biologics, Lonza Group AG and Pace Analytical Life Sciences, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Pharmaceutical Release Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Release Testing.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pharmaceutical Release Testing Market by Company

Charles River Laboratories

SGS SA

Catalent, Inc.

WuXi AppTec

Intertek Group plc

Labcorp Holdings

Samsung Biologics

Lonza Group AG

Pace Analytical Life Sciences

Frontage Laboratories

Curia Global

Cambrex

Alcami

Nelson Laboratories

Element Materials Technology

CMIC Holdings

Sumika Chemical Analysis Service

Tentamus Group

Syngene International

Aragen Life Sciences

RSSL

Nuvisan

Pharmaron

Eurofins Scientific SE

Thermo Fisher Scientific

Merck KGaA

Pharmaceutical Release Testing Segment by Type

Identity and Assay Testing

Purity and Impurity Testing

Potency and Bioactivity Testing

Others

Pharmaceutical Release Testing Segment by Application

Chemical Pharmaceutical Industry

Biopharmaceutical Industry

Cell and Gene Therapy Industry

Others

Pharmaceutical Release Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Release Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Release Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Release Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Pharmaceutical Release Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pharmaceutical Release Testing Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Pharmaceutical Release Testing Revenue Market Share by Type (2021-2026) Table 7. Global Pharmaceutical Release Testing Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Pharmaceutical Release Testing Revenue Market Share by Type (2027-2032) Table 9. Global Pharmaceutical Release Testing Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Pharmaceutical Release Testing Revenue Market Share by Application (2021-2026) Table 11. Global Pharmaceutical Release Testing Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Pharmaceutical Release Testing Revenue Market Share by Application (2027-2032) Table 13. Global Pharmaceutical Release Testing Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pharmaceutical Release Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pharmaceutical Release Testing Market Share by Region (2021-2026) Table 16. Global Pharmaceutical Release Testing Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pharmaceutical Release Testing Market Share by Region (2027-2032) Table 18. Pharmaceutical Release Testing Industry Trends Table 19. Pharmaceutical Release Testing Industry Drivers Table 20. Pharmaceutical Release Testing Industry Opportunities and Challenges Table 21. Pharmaceutical Release Testing Market Restraints Table 22. Global Top Pharmaceutical Release Testing Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Pharmaceutical Release Testing Revenue Market Share by Players (2021-2026) Table 24. Global Pharmaceutical Release Testing Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Pharmaceutical Release Testing, Headquarters and Area Served Table 26. Global Pharmaceutical Release Testing Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Pharmaceutical Release Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Pharmaceutical Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Pharmaceutical Release Testing Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Pharmaceutical Release Testing Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Pharmaceutical Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Pharmaceutical Release Testing Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Pharmaceutical Release Testing Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Pharmaceutical Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Pharmaceutical Release Testing Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Pharmaceutical Release Testing Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Pharmaceutical Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Pharmaceutical Release Testing Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Pharmaceutical Release Testing Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Pharmaceutical Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Pharmaceutical Release Testing Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Pharmaceutical Release Testing Market Size by Country (2027-2032) & (US$ Million) Table 45. Charles River Laboratories Company Information Table 46. Charles River Laboratories Business Overview Table 47. Charles River Laboratories Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 48. Charles River Laboratories Pharmaceutical Release Testing Product Portfolio Table 49. Charles River Laboratories Recent Developments Table 50. SGS SA Company Information Table 51. SGS SA Business Overview Table 52. SGS SA Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 53. SGS SA Pharmaceutical Release Testing Product Portfolio Table 54. SGS SA Recent Developments Table 55. Catalent, Inc. Company Information Table 56. Catalent, Inc. Business Overview Table 57. Catalent, Inc. Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 58. Catalent, Inc. Pharmaceutical Release Testing Product Portfolio Table 59. Catalent, Inc. Recent Developments Table 60. WuXi AppTec Company Information Table 61. WuXi AppTec Business Overview Table 62. WuXi AppTec Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 63. WuXi AppTec Pharmaceutical Release Testing Product Portfolio Table 64. WuXi AppTec Recent Developments Table 65. Intertek Group plc Company Information Table 66. Intertek Group plc Business Overview Table 67. Intertek Group plc Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 68. Intertek Group plc Pharmaceutical Release Testing Product Portfolio Table 69. Intertek Group plc Recent Developments Table 70. Labcorp Holdings Company Information Table 71. Labcorp Holdings Business Overview Table 72. Labcorp Holdings Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 73. Labcorp Holdings Pharmaceutical Release Testing Product Portfolio Table 74. Labcorp Holdings Recent Developments Table 75. Samsung Biologics Company Information Table 76. Samsung Biologics Business Overview Table 77. Samsung Biologics Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 78. Samsung Biologics Pharmaceutical Release Testing Product Portfolio Table 79. Samsung Biologics Recent Developments Table 80. Lonza Group AG Company Information Table 81. Lonza Group AG Business Overview Table 82. Lonza Group AG Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 83. Lonza Group AG Pharmaceutical Release Testing Product Portfolio Table 84. Lonza Group AG Recent Developments Table 85. Pace Analytical Life Sciences Company Information Table 86. Pace Analytical Life Sciences Business Overview Table 87. Pace Analytical Life Sciences Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 88. Pace Analytical Life Sciences Pharmaceutical Release Testing Product Portfolio Table 89. Pace Analytical Life Sciences Recent Developments Table 90. Frontage Laboratories Company Information Table 91. Frontage Laboratories Business Overview Table 92. Frontage Laboratories Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 93. Frontage Laboratories Pharmaceutical Release Testing Product Portfolio Table 94. Frontage Laboratories Recent Developments Table 95. Curia Global Company Information Table 96. Curia Global Business Overview Table 97. Curia Global Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 98. Curia Global Pharmaceutical Release Testing Product Portfolio Table 99. Curia Global Recent Developments Table 100. Cambrex Company Information Table 101. Cambrex Business Overview Table 102. Cambrex Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 103. Cambrex Pharmaceutical Release Testing Product Portfolio Table 104. Cambrex Recent Developments Table 105. Alcami Company Information Table 106. Alcami Business Overview Table 107. Alcami Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 108. Alcami Pharmaceutical Release Testing Product Portfolio Table 109. Alcami Recent Developments Table 110. Nelson Laboratories Company Information Table 111. Nelson Laboratories Business Overview Table 112. Nelson Laboratories Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 113. Nelson Laboratories Pharmaceutical Release Testing Product Portfolio Table 114. Nelson Laboratories Recent Developments Table 115. Element Materials Technology Company Information Table 116. Element Materials Technology Business Overview Table 117. Element Materials Technology Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 118. Element Materials Technology Pharmaceutical Release Testing Product Portfolio Table 119. Element Materials Technology Recent Developments Table 120. CMIC Holdings Company Information Table 121. CMIC Holdings Business Overview Table 122. CMIC Holdings Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 123. CMIC Holdings Pharmaceutical Release Testing Product Portfolio Table 124. CMIC Holdings Recent Developments Table 125. Sumika Chemical Analysis Service Company Information Table 126. Sumika Chemical Analysis Service Business Overview Table 127. Sumika Chemical Analysis Service Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 128. Sumika Chemical Analysis Service Pharmaceutical Release Testing Product Portfolio Table 129. Sumika Chemical Analysis Service Recent Developments Table 130. Tentamus Group Company Information Table 131. Tentamus Group Business Overview Table 132. Tentamus Group Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 133. Tentamus Group Pharmaceutical Release Testing Product Portfolio Table 134. Tentamus Group Recent Developments Table 135. Syngene International Company Information Table 136. Syngene International Business Overview Table 137. Syngene International Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 138. Syngene International Pharmaceutical Release Testing Product Portfolio Table 139. Syngene International Recent Developments Table 140. Aragen Life Sciences Company Information Table 141. Aragen Life Sciences Business Overview Table 142. Aragen Life Sciences Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 143. Aragen Life Sciences Pharmaceutical Release Testing Product Portfolio Table 144. Aragen Life Sciences Recent Developments Table 145. RSSL Company Information Table 146. RSSL Business Overview Table 147. RSSL Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 148. RSSL Pharmaceutical Release Testing Product Portfolio Table 149. RSSL Recent Developments Table 150. Nuvisan Company Information Table 151. Nuvisan Business Overview Table 152. Nuvisan Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 153. Nuvisan Pharmaceutical Release Testing Product Portfolio Table 154. Nuvisan Recent Developments Table 155. Pharmaron Company Information Table 156. Pharmaron Business Overview Table 157. Pharmaron Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 158. Pharmaron Pharmaceutical Release Testing Product Portfolio Table 159. Pharmaron Recent Developments Table 160. Eurofins Scientific SE Company Information Table 161. Eurofins Scientific SE Business Overview Table 162. Eurofins Scientific SE Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 163. Eurofins Scientific SE Pharmaceutical Release Testing Product Portfolio Table 164. Eurofins Scientific SE Recent Developments Table 165. Thermo Fisher Scientific Company Information Table 166. Thermo Fisher Scientific Business Overview Table 167. Thermo Fisher Scientific Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 168. Thermo Fisher Scientific Pharmaceutical Release Testing Product Portfolio Table 169. Thermo Fisher Scientific Recent Developments Table 170. Merck KGaA Company Information Table 171. Merck KGaA Business Overview Table 172. Merck KGaA Revenue in Pharmaceutical Release Testing Business (2021-2026) & (US$ Million) Table 173. Merck KGaA Pharmaceutical Release Testing Product Portfolio Table 174. Merck KGaA Recent Developments Table 175. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pharmaceutical Release Testing Product Image Figure 5. Global Pharmaceutical Release Testing Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Pharmaceutical Release Testing Market Share by Type: 2025 VS 2032 Figure 7. Identity and Assay Testing Product Figure 8. Purity and Impurity Testing Product Figure 9. Potency and Bioactivity Testing Product Figure 10. Others Product Figure 11. Global Pharmaceutical Release Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmaceutical Release Testing Market Share by Application: 2025 VS 2032 Figure 13. Chemical Pharmaceutical Industry Product Figure 14. Biopharmaceutical Industry Product Figure 15. Cell and Gene Therapy Industry Product Figure 16. Others Product Figure 17. Global Pharmaceutical Release Testing Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 18. Global Pharmaceutical Release Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Pharmaceutical Release Testing Market Share by Region: 2025 VS 2032 Figure 20. Global Pharmaceutical Release Testing Market Share by Players in 2025 Figure 21. Global Pharmaceutical Release Testing Manufacturers Established Date Figure 22. Global Top 5 and 10 Pharmaceutical Release Testing Players Market Share by Revenue in 2025 Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. North America Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Pharmaceutical Release Testing Market Share by Country (2021-2032) Figure 26. United States Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Canada Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Mexico Pharmaceutical Release Testing Market Share by Country (2021-2032) Figure 29. Europe Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Pharmaceutical Release Testing Market Share by Country (2021-2032) Figure 31. Germany Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. France Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. U.K. Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Italy Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Spain Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Russia Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Netherlands Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Nordic Countries Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Pharmaceutical Release Testing Market Share by Country (2021-2032) Figure 41. China Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. Japan Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. South Korea Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. India Pharmaceutical Release Testing Market Share by Country (2021-2032) Figure 46. Australia Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. China Taiwan Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. Southeast Asia Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. South America Pharmaceutical Release Testing Market Share by Country (2021-2032) Figure 51. Brazil Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Argentina Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Chile Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Colombia Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Peru Pharmaceutical Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. Charles River Laboratories Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 57. SGS SA Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 58. Catalent, Inc. Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 59. WuXi AppTec Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 60. Intertek Group plc Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 61. Labcorp Holdings Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 62. Samsung Biologics Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 63. Lonza Group AG Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 64. Pace Analytical Life Sciences Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 65. Frontage Laboratories Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 66. Curia Global Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 67. Cambrex Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 68. Alcami Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 69. Nelson Laboratories Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 70. Element Materials Technology Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 71. CMIC Holdings Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 72. Sumika Chemical Analysis Service Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 73. Tentamus Group Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 74. Syngene International Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 75. Aragen Life Sciences Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 76. RSSL Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 77. Nuvisan Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 78. Pharmaron Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 79. Eurofins Scientific SE Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 80. Thermo Fisher Scientific Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026) Figure 81. Merck KGaA Revenue Growth Rate in Pharmaceutical Release Testing Business (2021-2026)

Scope & coverage.

Types
  • Identity and Assay Testing
  • Purity and Impurity Testing
  • Potency and Bioactivity Testing
  • Others
Applications
  • Chemical Pharmaceutical Industry
  • Biopharmaceutical Industry
  • Cell and Gene Therapy Industry
  • Others
Companies covered
  • Charles River Laboratories
  • SGS SA
  • Catalent, Inc.
  • WuXi AppTec
  • Intertek Group plc
  • Labcorp Holdings
  • Samsung Biologics
  • Lonza Group AG
  • Pace Analytical Life Sciences
  • Frontage Laboratories
  • Curia Global
  • Cambrex
  • Alcami
  • Nelson Laboratories
  • Element Materials Technology
  • CMIC Holdings
  • Sumika Chemical Analysis Service
  • Tentamus Group
  • Syngene International
  • Aragen Life Sciences
  • RSSL
  • Nuvisan
  • Pharmaron
  • Eurofins Scientific SE
  • Thermo Fisher Scientific
  • Merck KGaA

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Pharmaceutical Release Testing by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Identity and Assay Testing
  5. 2.2.3 Purity and Impurity Testing
  6. 2.2.4 Potency and Bioactivity Testing
  7. 2.2.5 Others
  8. 2.3 Pharmaceutical Release Testing by Application
  9. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  10. 2.3.2 Chemical Pharmaceutical Industry
  11. 2.3.3 Biopharmaceutical Industry
  12. 2.3.4 Cell and Gene Therapy Industry
  13. 2.3.5 Others
  14. 2.4 Assumptions and Limitations
3 Pharmaceutical Release Testing Breakdown Data by Type
  1. 3.1 Global Pharmaceutical Release Testing Historic Market Size by Type (2021-2026)
  2. 3.2 Global Pharmaceutical Release Testing Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Release Testing Breakdown Data by Application
  1. 4.1 Global Pharmaceutical Release Testing Historic Market Size by Application (2021-2026)
  2. 4.2 Global Pharmaceutical Release Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Pharmaceutical Release Testing Market Perspective (2021-2032)
  2. 5.2 Global Pharmaceutical Release Testing Growth Trends by Region
  3. 5.2.1 Global Pharmaceutical Release Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Pharmaceutical Release Testing Historic Market Size by Region (2021-2026)
  5. 5.2.3 Pharmaceutical Release Testing Forecasted Market Size by Region (2027-2032)
  6. 5.3 Pharmaceutical Release Testing Market Dynamics
  7. 5.3.1 Pharmaceutical Release Testing Industry Trends
  8. 5.3.2 Pharmaceutical Release Testing Market Drivers
  9. 5.3.3 Pharmaceutical Release Testing Market Challenges
  10. 5.3.4 Pharmaceutical Release Testing Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Pharmaceutical Release Testing Players by Revenue
  2. 6.1.1 Global Top Pharmaceutical Release Testing Players by Revenue (2021-2026)
  3. 6.1.2 Global Pharmaceutical Release Testing Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Pharmaceutical Release Testing Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Pharmaceutical Release Testing Head Office and Area Served
  6. 6.4 Global Pharmaceutical Release Testing Players, Product Type & Application
  7. 6.5 Global Pharmaceutical Release Testing Manufacturers Established Date
  8. 6.6 Global Pharmaceutical Release Testing Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Pharmaceutical Release Testing Market Size (2021-2032)
  2. 7.2 North America Pharmaceutical Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Pharmaceutical Release Testing Market Size by Country (2021-2026)
  4. 7.4 North America Pharmaceutical Release Testing Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Pharmaceutical Release Testing Market Size (2021-2032)
  2. 8.2 Europe Pharmaceutical Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Pharmaceutical Release Testing Market Size by Country (2021-2026)
  4. 8.4 Europe Pharmaceutical Release Testing Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pharmaceutical Release Testing Market Size (2021-2032)
  2. 9.2 Asia-Pacific Pharmaceutical Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Pharmaceutical Release Testing Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Pharmaceutical Release Testing Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Pharmaceutical Release Testing Market Size (2021-2032)
  2. 10.2 South America Pharmaceutical Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Pharmaceutical Release Testing Market Size by Country (2021-2026)
  4. 10.4 South America Pharmaceutical Release Testing Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pharmaceutical Release Testing Market Size (2021-2032)
  2. 11.2 Middle East & Africa Pharmaceutical Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Pharmaceutical Release Testing Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Pharmaceutical Release Testing Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Charles River Laboratories
  2. 12.1.1 Charles River Laboratories Company Information
  3. 12.1.2 Charles River Laboratories Business Overview
  4. 12.1.3 Charles River Laboratories Revenue in Pharmaceutical Release Testing Business (2021-2026)
  5. 12.1.4 Charles River Laboratories Pharmaceutical Release Testing Product Portfolio
  6. 12.1.5 Charles River Laboratories Recent Developments
  7. 12.2 SGS SA
  8. 12.2.1 SGS SA Company Information
  9. 12.2.2 SGS SA Business Overview
  10. 12.2.3 SGS SA Revenue in Pharmaceutical Release Testing Business (2021-2026)
  11. 12.2.4 SGS SA Pharmaceutical Release Testing Product Portfolio
  12. 12.2.5 SGS SA Recent Developments
  13. 12.3 Catalent, Inc.
  14. 12.3.1 Catalent, Inc. Company Information
  15. 12.3.2 Catalent, Inc. Business Overview
  16. 12.3.3 Catalent, Inc. Revenue in Pharmaceutical Release Testing Business (2021-2026)
  17. 12.3.4 Catalent, Inc. Pharmaceutical Release Testing Product Portfolio
  18. 12.3.5 Catalent, Inc. Recent Developments
  19. 12.4 WuXi AppTec
  20. 12.4.1 WuXi AppTec Company Information
  21. 12.4.2 WuXi AppTec Business Overview
  22. 12.4.3 WuXi AppTec Revenue in Pharmaceutical Release Testing Business (2021-2026)
  23. 12.4.4 WuXi AppTec Pharmaceutical Release Testing Product Portfolio
  24. 12.4.5 WuXi AppTec Recent Developments
  25. 12.5 Intertek Group plc
  26. 12.5.1 Intertek Group plc Company Information
  27. 12.5.2 Intertek Group plc Business Overview
  28. 12.5.3 Intertek Group plc Revenue in Pharmaceutical Release Testing Business (2021-2026)
  29. 12.5.4 Intertek Group plc Pharmaceutical Release Testing Product Portfolio
  30. 12.5.5 Intertek Group plc Recent Developments
  31. 12.6 Labcorp Holdings
  32. 12.6.1 Labcorp Holdings Company Information
  33. 12.6.2 Labcorp Holdings Business Overview
  34. 12.6.3 Labcorp Holdings Revenue in Pharmaceutical Release Testing Business (2021-2026)
  35. 12.6.4 Labcorp Holdings Pharmaceutical Release Testing Product Portfolio
  36. 12.6.5 Labcorp Holdings Recent Developments
  37. 12.7 Samsung Biologics
  38. 12.7.1 Samsung Biologics Company Information
  39. 12.7.2 Samsung Biologics Business Overview
  40. 12.7.3 Samsung Biologics Revenue in Pharmaceutical Release Testing Business (2021-2026)
  41. 12.7.4 Samsung Biologics Pharmaceutical Release Testing Product Portfolio
  42. 12.7.5 Samsung Biologics Recent Developments
  43. 12.8 Lonza Group AG
  44. 12.8.1 Lonza Group AG Company Information
  45. 12.8.2 Lonza Group AG Business Overview
  46. 12.8.3 Lonza Group AG Revenue in Pharmaceutical Release Testing Business (2021-2026)
  47. 12.8.4 Lonza Group AG Pharmaceutical Release Testing Product Portfolio
  48. 12.8.5 Lonza Group AG Recent Developments
  49. 12.9 Pace Analytical Life Sciences
  50. 12.9.1 Pace Analytical Life Sciences Company Information
  51. 12.9.2 Pace Analytical Life Sciences Business Overview
  52. 12.9.3 Pace Analytical Life Sciences Revenue in Pharmaceutical Release Testing Business (2021-2026)
  53. 12.9.4 Pace Analytical Life Sciences Pharmaceutical Release Testing Product Portfolio
  54. 12.9.5 Pace Analytical Life Sciences Recent Developments
  55. 12.10 Frontage Laboratories
  56. 12.10.1 Frontage Laboratories Company Information
  57. 12.10.2 Frontage Laboratories Business Overview
  58. 12.10.3 Frontage Laboratories Revenue in Pharmaceutical Release Testing Business (2021-2026)
  59. 12.10.4 Frontage Laboratories Pharmaceutical Release Testing Product Portfolio
  60. 12.10.5 Frontage Laboratories Recent Developments
  61. 12.11 Curia Global
  62. 12.11.1 Curia Global Company Information
  63. 12.11.2 Curia Global Business Overview
  64. 12.11.3 Curia Global Revenue in Pharmaceutical Release Testing Business (2021-2026)
  65. 12.11.4 Curia Global Pharmaceutical Release Testing Product Portfolio
  66. 12.11.5 Curia Global Recent Developments
  67. 12.12 Cambrex
  68. 12.12.1 Cambrex Company Information
  69. 12.12.2 Cambrex Business Overview
  70. 12.12.3 Cambrex Revenue in Pharmaceutical Release Testing Business (2021-2026)
  71. 12.12.4 Cambrex Pharmaceutical Release Testing Product Portfolio
  72. 12.12.5 Cambrex Recent Developments
  73. 12.13 Alcami
  74. 12.13.1 Alcami Company Information
  75. 12.13.2 Alcami Business Overview
  76. 12.13.3 Alcami Revenue in Pharmaceutical Release Testing Business (2021-2026)
  77. 12.13.4 Alcami Pharmaceutical Release Testing Product Portfolio
  78. 12.13.5 Alcami Recent Developments
  79. 12.14 Nelson Laboratories
  80. 12.14.1 Nelson Laboratories Company Information
  81. 12.14.2 Nelson Laboratories Business Overview
  82. 12.14.3 Nelson Laboratories Revenue in Pharmaceutical Release Testing Business (2021-2026)
  83. 12.14.4 Nelson Laboratories Pharmaceutical Release Testing Product Portfolio
  84. 12.14.5 Nelson Laboratories Recent Developments
  85. 12.15 Element Materials Technology
  86. 12.15.1 Element Materials Technology Company Information
  87. 12.15.2 Element Materials Technology Business Overview
  88. 12.15.3 Element Materials Technology Revenue in Pharmaceutical Release Testing Business (2021-2026)
  89. 12.15.4 Element Materials Technology Pharmaceutical Release Testing Product Portfolio
  90. 12.15.5 Element Materials Technology Recent Developments
  91. 12.16 CMIC Holdings
  92. 12.16.1 CMIC Holdings Company Information
  93. 12.16.2 CMIC Holdings Business Overview
  94. 12.16.3 CMIC Holdings Revenue in Pharmaceutical Release Testing Business (2021-2026)
  95. 12.16.4 CMIC Holdings Pharmaceutical Release Testing Product Portfolio
  96. 12.16.5 CMIC Holdings Recent Developments
  97. 12.17 Sumika Chemical Analysis Service
  98. 12.17.1 Sumika Chemical Analysis Service Company Information
  99. 12.17.2 Sumika Chemical Analysis Service Business Overview
  100. 12.17.3 Sumika Chemical Analysis Service Revenue in Pharmaceutical Release Testing Business (2021-2026)
  101. 12.17.4 Sumika Chemical Analysis Service Pharmaceutical Release Testing Product Portfolio
  102. 12.17.5 Sumika Chemical Analysis Service Recent Developments
  103. 12.18 Tentamus Group
  104. 12.18.1 Tentamus Group Company Information
  105. 12.18.2 Tentamus Group Business Overview
  106. 12.18.3 Tentamus Group Revenue in Pharmaceutical Release Testing Business (2021-2026)
  107. 12.18.4 Tentamus Group Pharmaceutical Release Testing Product Portfolio
  108. 12.18.5 Tentamus Group Recent Developments
  109. 12.19 Syngene International
  110. 12.19.1 Syngene International Company Information
  111. 12.19.2 Syngene International Business Overview
  112. 12.19.3 Syngene International Revenue in Pharmaceutical Release Testing Business (2021-2026)
  113. 12.19.4 Syngene International Pharmaceutical Release Testing Product Portfolio
  114. 12.19.5 Syngene International Recent Developments
  115. 12.20 Aragen Life Sciences
  116. 12.20.1 Aragen Life Sciences Company Information
  117. 12.20.2 Aragen Life Sciences Business Overview
  118. 12.20.3 Aragen Life Sciences Revenue in Pharmaceutical Release Testing Business (2021-2026)
  119. 12.20.4 Aragen Life Sciences Pharmaceutical Release Testing Product Portfolio
  120. 12.20.5 Aragen Life Sciences Recent Developments
  121. 12.21 RSSL
  122. 12.21.1 RSSL Company Information
  123. 12.21.2 RSSL Business Overview
  124. 12.21.3 RSSL Revenue in Pharmaceutical Release Testing Business (2021-2026)
  125. 12.21.4 RSSL Pharmaceutical Release Testing Product Portfolio
  126. 12.21.5 RSSL Recent Developments
  127. 12.22 Nuvisan
  128. 12.22.1 Nuvisan Company Information
  129. 12.22.2 Nuvisan Business Overview
  130. 12.22.3 Nuvisan Revenue in Pharmaceutical Release Testing Business (2021-2026)
  131. 12.22.4 Nuvisan Pharmaceutical Release Testing Product Portfolio
  132. 12.22.5 Nuvisan Recent Developments
  133. 12.23 Pharmaron
  134. 12.23.1 Pharmaron Company Information
  135. 12.23.2 Pharmaron Business Overview
  136. 12.23.3 Pharmaron Revenue in Pharmaceutical Release Testing Business (2021-2026)
  137. 12.23.4 Pharmaron Pharmaceutical Release Testing Product Portfolio
  138. 12.23.5 Pharmaron Recent Developments
  139. 12.24 Eurofins Scientific SE
  140. 12.24.1 Eurofins Scientific SE Company Information
  141. 12.24.2 Eurofins Scientific SE Business Overview
  142. 12.24.3 Eurofins Scientific SE Revenue in Pharmaceutical Release Testing Business (2021-2026)
  143. 12.24.4 Eurofins Scientific SE Pharmaceutical Release Testing Product Portfolio
  144. 12.24.5 Eurofins Scientific SE Recent Developments
  145. 12.25 Thermo Fisher Scientific
  146. 12.25.1 Thermo Fisher Scientific Company Information
  147. 12.25.2 Thermo Fisher Scientific Business Overview
  148. 12.25.3 Thermo Fisher Scientific Revenue in Pharmaceutical Release Testing Business (2021-2026)
  149. 12.25.4 Thermo Fisher Scientific Pharmaceutical Release Testing Product Portfolio
  150. 12.25.5 Thermo Fisher Scientific Recent Developments
  151. 12.26 Merck KGaA
  152. 12.26.1 Merck KGaA Company Information
  153. 12.26.2 Merck KGaA Business Overview
  154. 12.26.3 Merck KGaA Revenue in Pharmaceutical Release Testing Business (2021-2026)
  155. 12.26.4 Merck KGaA Pharmaceutical Release Testing Product Portfolio
  156. 12.26.5 Merck KGaA Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst